{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:02:07Z","timestamp":1794668527173,"version":"4.9.1"},"reference-count":21,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There is no consensus on the best donor for children with nonmalignant disorders and immune deficiencies in the absence of a matched related donor (MRD). We evaluated the 2-year overall survival (OS) after umbilical cord blood transplantation (UCBT) in patients with nonmalignant disorders from 2009 to 2020 enrolled in a prospective clinical trial using either 5\/6 or 6\/6 UCB as the cell source. Patients receive a fully ablative busulfan, cyclophosphamide, and fludarabine without serotherapy. Fifty-five children were enrolled, median age 5 months (range, 1-111 months); primary immune deficiency (45), metabolic (5), hemophagocytic lymphohistiocytosis (1), and hematologic disorders (4). Twenty-six patients had persistent infections before transplant. Nineteen of them (34%) were 6\/6 matched, and 36 (66%) were 5\/6 human leukocyte antigen\u2013matched. The OS at 2 years was 91% (95% cumulative incidence, 79-96), with a median follow-up of 4.3 years. The median time to neutrophil and platelet recovery were 17 days (range, 5-39 days) and 37 days (range, 20-92 days), respectively. All but one evaluable patient achieved full donor chimerism. The cumulative incidence of acute GVHD grades 2-4 on day 100 was 16% (n\u00a0= 9). All patients with viral infections at the time of transplant cleared the infection at a median time of 54\u00a0days (range, 44-91 days). All evaluable patients underwent correction of their immune or metabolic defects. We conclude that in the absence of MRD, UCBT following myeloablative conditioning without serotherapy is an excellent curative option in young children with nonmalignant disorders. This trial has been registered at www.clinicaltrials.gov as NCT00950846.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022009038","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:03:31Z","timestamp":1669899811000},"page":"1823-1830","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7141-2457","authenticated-orcid":false,"given":"Caridad","family":"Martinez","sequence":"first","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0196-806X","authenticated-orcid":false,"given":"Paibel","family":"Aguayo-Hiraldo","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-6337","authenticated-orcid":false,"given":"Natalia","family":"Chaimowitz","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Forbes","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Rider","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nicholas","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Seeborg","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Chinen","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-5457","authenticated-orcid":false,"given":"Ivan","family":"Chinn","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-7822","authenticated-orcid":false,"given":"Carla","family":"Davis","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Roseblatt","sequence":"additional","affiliation":[{"name":"3Immunology, Dell Children\u2019s Medical Center and SFC, Austin, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenora","family":"Noroski","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Omer","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"John","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Yassine","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Naik","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Craddock","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Bhar","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Allen","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-8424","authenticated-orcid":false,"given":"Nabil","family":"Ahmed","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir","family":"Sasa","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Steffin","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Doherty","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"George","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-0248","authenticated-orcid":false,"given":"Baheyeldin","family":"Salem","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8652-4400","authenticated-orcid":false,"given":"Brian","family":"Friend","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-7871","authenticated-orcid":false,"given":"Meenakshi","family":"Hegde","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-7698","authenticated-orcid":false,"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Leen","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Pe\u00f1a","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfen","family":"Wu","sequence":"additional","affiliation":[{"name":"4Biostatistics Shared Resource, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Celine","family":"Hanson","sequence":"additional","affiliation":[{"name":"2Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Krance","sequence":"additional","affiliation":[{"name":"1Center for Cell and Gene Therapy, Bayor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"4","key":"2023050516095608100_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"9577","key":"2023050516095608100_bib2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"2023050516095608100_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"2023050516095608100_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminhematol.2009.10.009","article-title":"Unrelated umbilical cord blood transplantation and immune reconstitution","volume":"47","author":"Szabolcs","year":"2010","journal-title":"Semin Hematol"},{"issue":"1, suppl","key":"2023050516095608100_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbmt.2007.10.016","article-title":"Immune reconstitution in children after unrelated cord blood transplantation","volume":"14","author":"Szabolcs","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"2023050516095608100_bib6","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2023050516095608100_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2011.08994.x","article-title":"Omission of in\u00a0vivo T cell depletion promotes rapid expansion of na\u00efve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant","volume":"156","author":"Chiesa","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"2023050516095608100_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/bloodadvances.2017015487","article-title":"Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation","volume":"2","author":"de Koning","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"2023050516095608100_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"1","key":"2023050516095608100_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2013-05-502385","article-title":"Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome","volume":"123","author":"Lindemans","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2023050516095608100_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2141.2010.08409.x","article-title":"Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children","volume":"152","author":"Renard","year":"2011","journal-title":"Br J Haematol"},{"issue":"22","key":"2023050516095608100_bib12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental-blood transplants from unrelated donors","volume":"339","author":"Rubinstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"2023050516095608100_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/CCO.0b013e328335a56e","article-title":"Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution","volume":"22","author":"Escalon","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"13","key":"2023050516095608100_bib14","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2007-05-092130","article-title":"Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing","volume":"110","author":"Komanduri","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2023050516095608100_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/bloodadvances.2019000836","article-title":"Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin","volume":"4","author":"Politikos","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2023050516095608100_bib16","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/S2352-3026(21)00375-6","article-title":"Individualized dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single arm, phase 2 clinical trial","volume":"9","author":"Admiraal","year":"2022","journal-title":"Lancet Haematol"},{"issue":"4","key":"2023050516095608100_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"11","key":"2023050516095608100_bib18","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2008-07-163238","article-title":"Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors","volume":"113","author":"MacMillan","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2023050516095608100_bib19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/JVI.01850-14","article-title":"Cognate CD4 T -cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation","volume":"89","author":"Flinsenberg","year":"2015","journal-title":"J\u00a0Virol"},{"issue":"24","key":"2023050516095608100_bib20","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/bloodadvances.2017010827","article-title":"Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4+ T\u00a0cell-reconstitution","volume":"1","author":"Hiwakar","year":"2017","journal-title":"Blood Adv"},{"issue":"22","key":"2023050516095608100_bib21","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2011-06-363572","article-title":"Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?","volume":"119","author":"Fernandes","year":"2012","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/9\/1823\/2049170\/blooda_adv-2022-009038-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/9\/1823\/2049170\/blooda_adv-2022-009038-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:10:41Z","timestamp":1683303041000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/9\/1823\/493380\/Cord-blood-transplantation-for-nonmalignant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,5,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009038","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}